Results 21 to 30 of about 715 (161)

Clinical status of corneal haze in wounded eyes -/+ eyedrop.

open access: yes, 2022
Representative slit lamp images (A) and stereo biomicroscopy images (B) demonstrating levels of corneal haze from day 0 to 28 in Group-1 and Group-3 eyes. Eyedrop-treated eyes showed substantially reduced corneal haze.
Rajiv R. Mohan (11927137)   +4 more
core   +1 more source

Representative immunofluorescence of α-SMA protein in naïve and wounded eyes -/+ eyedrop.

open access: yes, 2022
A significantly increased α-SMA+ cells were found in alkali wounded rabbit corneas (B) compared to the naïve corneas (A). Eyedrop treatment after injury significantly decreased α-SMA+ cells in rabbit corneas (C) compared to alkali injured rabbit corneas ...
Rajiv R. Mohan (11927137)   +4 more
core   +1 more source

Eyedrop vaccination: an immunization route with promises for effective responses to pandemics

open access: yes, 2021
Introduction: Mucosal vaccines have several advantages over parenteral vaccines. They induce both systemic and mucosal antigen-specific immune responses, allow easy administration, and bypass the need for trained medical personnel.
윤상철   +9 more
core   +1 more source

IN VITRO ANTIMICROBIAL ACTIVITY EVALUATION FOR DIFFERENT PHARMACEUTICAL DOSAGE FORMS OF CIPROFLOXACIN IN ADEN-YEMEN

open access: yesمجلّة جامعة عدن للعلوم الأساسيّة والتّطبيقيّة, 2020
Ciprofloxacin (CIP) is classified as a second-generation fluoroquinolone structurally similar to nalidixic acid. It is a widely used antibiotic to treat different types of bacterial infections.
Wafa F. S. Badulla   +2 more
doaj   +1 more source

Hospital-prepared low-dose atropine eye drops for myopia progression control using atropine sulfate injection diluted in normal saline and lubricants

open access: yesBMC Research Notes, 2022
Objective As low-dose atropine eye-drops for myopia progression control prepared in-house by diluting the commercial 0.1% atropine eye-drop with sterile water or normal saline has been a common practice whereas atropine injection is readily available and
Nuthida Wongwirawat   +3 more
doaj   +1 more source

Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial

open access: yesTrials, 2021
Background The prevalence of myopia is increasing worldwide and is presently recognized as a major public health issue. Researchers and clinicians have been devoted in exploring appropriate clinical interventions to slow its progression in children ...
Ying Yuan   +8 more
doaj   +1 more source

In-Situ Thermoresponsive Hydrogel Containing Resveratrol-Loaded Nanoparticles as a Localized Drug Delivery Platform for Dry Eye Disease

open access: yesAntioxidants, 2023
Dry eye disease (DED) is a dynamic and complex disease that can cause significant damage to the ocular surface and discomfort, compromising the patient’s quality of life.
Ilenia De Luca   +5 more
doaj   +1 more source

Safety evaluation of eyedrop mOMVs in mice.

open access: yes, 2014
Groups of BALB/c mice were administered with 10 µg of mOMVs or wtOMVs resolved in 5 µl of PBS by eyedrop on each eye or 10 µg of wtOMVs resolved in 100 µl of PBS intraperitoneally. (A) Body weight changes were monitored on a daily basis for 5 days.
Eun-Do Kim (599727)   +7 more
core   +1 more source

Coated Zein Polymeric Nanoparticles Loaded with Amlodipine as a Repurposed Antibacterial Ocular Cure for MRSA-Induced Infection: Optimization, In Vitro, Ex Vivo, and In Vivo Assessments

open access: yesPharmaceutics
Background: Amlodipine besylate (AML) is recognized as a calcium channel blocker curative for hypertension. However, the drug emerged recently as an antibacterial cure that competently prevails over resistant strains.
Alaa S. Eita   +3 more
doaj   +1 more source

GHRHR Deficiency Enhances Retinal Ganglion Cell Survival and Visual Functions in Experimental Glaucoma by Inhibiting Ferroptosis

open access: yesAdvanced Science, EarlyView.
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy